BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05467670-completion@plaintrial.com
DTSTAMP:20261028T231020Z
DTSTART;VALUE=DATE:20310122
SUMMARY:Safety and Efficacy of Anti-CD47\, ALX148 in Combination With Lipos
 omal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian
  Cancer — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT05467670
URL:https://plaintrial.com/trial/NCT05467670
END:VEVENT
END:VCALENDAR